+

PE20081383A1 - Inhibidores benzoimidazolicos de trpv1 - Google Patents

Inhibidores benzoimidazolicos de trpv1

Info

Publication number
PE20081383A1
PE20081383A1 PE2007001787A PE2007001787A PE20081383A1 PE 20081383 A1 PE20081383 A1 PE 20081383A1 PE 2007001787 A PE2007001787 A PE 2007001787A PE 2007001787 A PE2007001787 A PE 2007001787A PE 20081383 A1 PE20081383 A1 PE 20081383A1
Authority
PE
Peru
Prior art keywords
alkyl
halogen
phenoximethyl
bencensulfonamide
benzoimidazol
Prior art date
Application number
PE2007001787A
Other languages
English (en)
Inventor
Wing S Cheung
Daniel J Parks
William H Parsons
Sharmila Patel
Mark R Player
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39536675&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20081383(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PE20081383A1 publication Critical patent/PE20081383A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/50—1,3-Diazoles; Hydrogenated 1,3-diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Agronomy & Crop Science (AREA)
  • Neurology (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS BENZOIMIDAZOLICOS DE FORMULA (I) DONDE LAS LINEAS PUNTEADAS SON UN DOBLE ENLACE TAUTOMERICO, p ES DE 0 A 2; q ES DE 0 A 2; r ES DE 0 A 3; L ES X-ALQUILO(C1-C3) O ALQUILO(C1-C3)-Y-, EN DONDE X E Y SON CADA UNO O, S, SO, SO2, ENTRE OTROS; A1 ES INDANILO, FENILO, NAFTILO, PIRIDINILO, ENTRE OTROS; R1 ES H, HIDROXI, HALOGENO, ALQUILO(C1-C6), CICLOALQUILO(C3-C8), ENTRE OTROS; R2 ES HALOGENO, ALQUILO(C1-C4), ALCOXI(C1-C4), NITRO, ENTRE OTROS; R3a Y R3b SON CADA UNO H O ALQUILO(C1-C4); R4 ES HALOGENO, NITRO, CN, ALQUILO(C1-C6); R5 ES HALOGENO, HIDROXI, ALQUILO(C1-C4), NITRO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: 2-[2-(4-TRIFLUOROMETIL-FENOXIMETIL)-1H-BENZOIMIDAZOL-5-IL]-BENCENSULFONAMIDA, 2-[2-(2-FLUORO-FENOXIMETIL)-1H-BENZOIMIDAZOL-5-IL]-BENCENSULFONAMIDA, 2-[2-(3-FLUORO-FENOXIMETIL)-1H-BENZOIMIDAZOL-5-IL]-BENCENSULFONAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DEL RECEPTOR VAINILLOIDE TRPV1 O RECEPTOR DE CAPSAICINA SIENDO UTILES EN EL TRATAMIENTO DE DOLOR CRONICO O AGUDO
PE2007001787A 2006-12-15 2007-12-13 Inhibidores benzoimidazolicos de trpv1 PE20081383A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87021206P 2006-12-15 2006-12-15

Publications (1)

Publication Number Publication Date
PE20081383A1 true PE20081383A1 (es) 2008-09-18

Family

ID=39536675

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007001787A PE20081383A1 (es) 2006-12-15 2007-12-13 Inhibidores benzoimidazolicos de trpv1

Country Status (17)

Country Link
US (1) US7612211B2 (es)
EP (1) EP2124563B1 (es)
JP (1) JP5746471B2 (es)
KR (1) KR101503286B1 (es)
AR (1) AR064356A1 (es)
AU (1) AU2007333990A1 (es)
BR (1) BRPI0721169A2 (es)
CA (1) CA2672856C (es)
CL (1) CL2007003636A1 (es)
ES (1) ES2551709T3 (es)
MX (1) MX2009006473A (es)
NZ (1) NZ598485A (es)
PE (1) PE20081383A1 (es)
TW (1) TWI425943B (es)
UY (1) UY30787A1 (es)
WO (1) WO2008076752A1 (es)
ZA (1) ZA200904920B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7951829B2 (en) * 2006-05-03 2011-05-31 Janssen Pharmaceutica Nv Benzimidazole modulators of VR1
US20100144717A1 (en) * 2006-12-15 2010-06-10 Janelle Comita-Prevoir 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents
EP2203411B1 (en) 2007-09-20 2016-01-06 Ramot at Tel-Aviv University Ltd. N-phenyl anthranilic acid derivatives and uses thereof
US8217060B2 (en) 2009-05-15 2012-07-10 Janssen Pharmaceutica, Nv Benzimidazole derivatives useful as TRP M8 receptor modulators
EP2390245A1 (en) * 2010-05-26 2011-11-30 Nabriva Therapeutics AG Enantiomerically pure amines
CA2828456C (en) * 2011-03-03 2021-05-04 Zalicus Pharmaceuticals Ltd. N-benzl-amino-carboxamide inhibitors of the sodium channel
US9260436B2 (en) 2012-06-22 2016-02-16 Sumitomo Chemical Company, Limited Fused heterocyclic compound
EP2700431A1 (en) 2012-08-24 2014-02-26 AnalytiCon Discovery GmbH Plant extracts for modulating TRPV1 function
LT6064B (lt) 2012-10-15 2014-08-25 Vilniaus Universitetas Fluorinti benzensulfonamidai kaip karboanhidrazės inhibitoriai
EP3547991A1 (en) 2016-12-02 2019-10-09 Symrise AG Cosmetic blends
US11427531B2 (en) 2017-10-09 2022-08-30 Ramot At Tel-Aviv University Ltd. Modulators of potassium ion and TRPV1 channels and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3182070A (en) 1962-05-24 1965-05-04 Dow Chemical Co Benzimidazole compounds
FR2766822B1 (fr) * 1997-07-30 2001-02-23 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6299796B1 (en) 1997-12-18 2001-10-09 Fuji Photo Film Co., Ltd. Styryl compound, method for the preparation thereof and electroluminescent element employing the same
JP4555082B2 (ja) 2002-08-08 2010-09-29 アムジエン・インコーポレーテツド バニロイド受容体リガンドおよびそれの治療での使用
WO2004078261A1 (en) * 2003-03-07 2004-09-16 The University Court Of The University Of Aberdeen Cannabinoid receptor inverse agonists and neutral antagonists as therapeutic agents for the treatment of bone disorders
AU2004285052A1 (en) * 2003-10-31 2005-05-12 Neurogen Corporation 4-amino (AZA) quinoline derivatives as capsaicin receptor agonists
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
WO2006078907A1 (en) * 2005-01-20 2006-07-27 Amgen Inc. 2-substituted benzimidazole derivatives as vanilloid receptor ligands and their use in treatments
US7951829B2 (en) * 2006-05-03 2011-05-31 Janssen Pharmaceutica Nv Benzimidazole modulators of VR1

Also Published As

Publication number Publication date
CA2672856A1 (en) 2008-06-26
BRPI0721169A2 (pt) 2014-03-18
MX2009006473A (es) 2009-08-25
CA2672856C (en) 2016-02-02
KR101503286B1 (ko) 2015-03-17
TW200843747A (en) 2008-11-16
WO2008076752A1 (en) 2008-06-26
JP2010513298A (ja) 2010-04-30
JP5746471B2 (ja) 2015-07-08
EP2124563B1 (en) 2015-07-29
NZ598485A (en) 2013-08-30
ZA200904920B (en) 2010-09-29
TWI425943B (zh) 2014-02-11
US7612211B2 (en) 2009-11-03
ES2551709T3 (es) 2015-11-23
EP2124563A4 (en) 2011-04-20
AR064356A1 (es) 2009-04-01
US20080146637A1 (en) 2008-06-19
KR20090090386A (ko) 2009-08-25
EP2124563A1 (en) 2009-12-02
AU2007333990A1 (en) 2008-06-26
UY30787A1 (es) 2008-07-03
CL2007003636A1 (es) 2008-06-20

Similar Documents

Publication Publication Date Title
PE20081383A1 (es) Inhibidores benzoimidazolicos de trpv1
PE20090641A1 (es) Amidas heterociclicas
PE20141375A1 (es) Activadores de glucoquinasa
PE20090237A1 (es) Derivados de sulfonamidas como inhibidores de los canales de sodio
PE20070528A1 (es) Compuestos heterociclicos como ligandos del receptor vaniloide del subtipo 1
PE20091623A1 (es) DERIVADOS DE 1H-PIRAZOLO[3,4-b]PIRIDINA COMO INHIBIDORES DE RAF QUINASA
PE20061150A1 (es) Derivados de n-(n-sulfonilaminoarilmetil)ciclopropanocarboxamida sustituidos como antagonistas del receptor vainilloide tipo 1 (vdr1)
PE20091561A1 (es) Compuestos inhibidores de raf y metodos para su uso
PE20120632A1 (es) Inhibidores de bace
PE20070016A1 (es) Compuestos heterociclicos n-enlazados como antagonistas del receptor p2y1
PE20050874A1 (es) Compuestos de bencimidazolona que tienen actividad agonista del receptor 5-ht4
PE20090694A1 (es) Compuestos moduladores de sirtuinas
PE20110598A1 (es) Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38
PE20080065A1 (es) Compuestos derivados de bencimidazol como moduladores del receptor vainilloide vr1
NO20084418L (no) Azolopyridin-3-on derivater som inhibitorer av endoteliallipase
AR048315A1 (es) Compuestos heterociclicos inhibidores de la produccion de citocinas; composiciones farmaceuticas que los contienen y su uso en el tratamiento de enfermedades inflamatorias y oncologicas.
PE20090982A1 (es) Derivados de piperidina como inhibidores de la proteina de transferencia de colesteril-ester (cetp)
PE20081845A1 (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
PE20080906A1 (es) Derivados heteroarilo como inhibidores de citocina
PE20080061A1 (es) Compuestos derivados de amida como inhibidores de los canales de potasio task-1 y task-3
PE20091466A1 (es) Derivados de 4,5-dihidro-oxazol-2-il-amina
PE20090288A1 (es) Derivados de quinoxalina como inhibidores de la pi3 quinasa
PE20091000A1 (es) Inhibidores de la replicacion del virus de la inmunodeficiencia humana
PE20080319A1 (es) Dihidrotienopirimidinas como agentes inhibidores de pde-4
NO20091590L (no) Heterocykliske amidforbindelser anvendbare som kinaseinhibitorer

Legal Events

Date Code Title Description
FC Refusal
点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载